Literature DB >> 31159596

Rabdosia rubescens Linn: green synthesis of gold nanoparticles and their anticancer effects against human lung cancer cells A549.

Xi Zhang1, Zhenyue Tan2, Kunjing Jia3, Wenzhi Zhang3, Minyan Dang3.   

Abstract

Nanomedicine is a rapidly emerging field and is reported to be a promising tool for treating various diseases. Green synthesized nanoparticles are documented to possess a potent anticancer effect. Rabdosia rubescens is a Chinese plant which is also one of the components of PC-SPES and used to treat prostate cancer. In the present study, we synthesized the gold nanoparticles from R. rubescens (RR-AuNP) and analyzed its anticancer activity against the lung carcinoma A549 cell lines. Since lung cancer is reported to be with increased morbidity and decreased survival rate. The biosynthesized RR-AuNP were confirmed using UV-Visible spectrophotometer, size and shape of RR-AuNP were assessed by DLS, TEM and EDX. The biomolecules present in RR-AuNP and its topographical structure were detected using FTIR, SAED and AFM analysis. MTT assay was performed to detect the IC50 dose of RR-AuNP and its apoptotic effect was assessed by detecting the caspases activation, ROS generation. The anticancer effect of RR-AuNP was confirmed by DAPI staining, TUNEL assay and its molecular mechanism were confirmed by assessing the apoptotic signalling molecules protein expression. Our results illustrate that RR-AuNP showed a strong absorption peak at 550 nm and the RRAuNP were polydispersed nanospheres with size of 130 nm. RR-AuNP IC50 dose against A549 lung carcinoma cell line was detected to be at 25 µg/ml. The results of DAPI staining, TUNEL and immunoblotting analysis confirms both the 25 µg/ml and 50 µg/ml of RR-AuNP possess potent anticancer and apoptotic effect, suggesting that RR-AuNP that it may be a persuasive molecule to treat lung cancer.

Entities:  

Keywords:  A549; Nanomedicine; anticancer; apoptosis; lung cancer

Mesh:

Substances:

Year:  2019        PMID: 31159596     DOI: 10.1080/21691401.2019.1620249

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  6 in total

Review 1.  Phytosynthesized Metallic Nanoparticles-between Nanomedicine and Toxicology. A Brief Review of 2019's Findings.

Authors:  Irina Fierascu; Ioana Catalina Fierascu; Roxana Ioana Brazdis; Anda Maria Baroi; Toma Fistos; Radu Claudiu Fierascu
Journal:  Materials (Basel)       Date:  2020-01-25       Impact factor: 3.623

2.  Methotrexate Gold Nanocarriers: Loading and Release Study: Its Activity in Colon and Lung Cancer Cells.

Authors:  Beatriz Álvarez-González; Marisa Rozalen; María Fernández-Perales; Miguel A Álvarez; Manuel Sánchez-Polo
Journal:  Molecules       Date:  2020-12-21       Impact factor: 4.411

Review 3.  Recent Developments in Metallic Nanomaterials for Cancer Therapy, Diagnosing and Imaging Applications.

Authors:  Dan Nicolae Păduraru; Daniel Ion; Adelina-Gabriela Niculescu; Florentina Mușat; Octavian Andronic; Alexandru Mihai Grumezescu; Alexandra Bolocan
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

4.  Green synthesis and characterization of gold nanoparticles from Pholiota adiposa and their anticancer effects on hepatic carcinoma.

Authors:  Zhongwei Yang; Zijing Liu; Junmo Zhu; Jie Xu; Youwei Pu; Yixi Bao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

5.  Apoptotic and Antioxidant Activity of Gold Nanoparticles Synthesized Using Marine Brown Seaweed: An In Vitro Study.

Authors:  S Rajeshkumar; R P Parameswari; J Jayapriya; M Tharani; Huma Ali; Nada H Aljarba; Saad Alkahtani; Saud Alarifi
Journal:  Biomed Res Int       Date:  2022-07-13       Impact factor: 3.246

6.  Synthesis of Biogenic Gold Nanoparticles from Terminalia mantaly Extracts and the Evaluation of Their In Vitro Cytotoxic Effects in Cancer Cells.

Authors:  Michele S Majoumouo; Jyoti R Sharma; Nicole R S Sibuyi; Marius B Tincho; Fabrice F Boyom; Mervin Meyer
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.